Role
10%+ Owner
Signature
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. By: Wellington Management Company LLP, as Investment Adviser /s/ Peter McIsaac, Authorized Person
Stock symbol
CRGX
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
3
Date filed
11/13/2023, 09:31 AM
Next filing
Sep 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRGX Series A-1 Preferred Stock Sep 14, 2023 Common Stock 737K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A-1 Preferred Stock is convertible into shares of the Issuer's Common Stock on a 13.5685-for-one basis at any time at the holder's election. Upon the closing of the Issuer's initial public offering, all such shares of Series A-1 Preferred Stock will automatically convert into the number of shares of Common Stock of the Issuer shown in column 3. The Series A-1 Preferred Stock has no expiration date.